Clinical Trial Update: Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating disulfiram-copper gluconate in metastatic pancreatic cancer with rising CA19-9 during standard regimens; study terminated with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Disulfiram-Copper gluconate (disulfiram-copper gluconate)

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-10-18